Details for Patent: 7,312,237
✉ Email this page to a colleague
Which drugs does patent 7,312,237 protect, and when does it expire?
Patent 7,312,237 protects IXEMPRA KIT and is included in one NDA.
Protection for IXEMPRA KIT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirty-four patent family members in twenty-six countries.
Summary for Patent: 7,312,237
Title: | Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases |
Abstract: | Compositions and methods are disclosed which are useful of the treatment and prevention of proliferative disorders. |
Inventor(s): | Lee; Francis Y. F. (Yardley, PA) |
Assignee: | Bristol-Myers Squibb Co. (Princeton, NJ) |
Application Number: | 10/091,061 |
Patent Claim Types: see list of patent claims | Use; Delivery; |
Drugs Protected by US Patent 7,312,237
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
R-pharm Us Llc | IXEMPRA KIT | ixabepilone | INJECTABLE;INTRAVENOUS | 022065-001 | Oct 16, 2007 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
R-pharm Us Llc | IXEMPRA KIT | ixabepilone | INJECTABLE;INTRAVENOUS | 022065-002 | Oct 16, 2007 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,312,237
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 554756 | ⤷ Sign Up | |||
Australia | 2002248542 | ⤷ Sign Up | |||
Bulgaria | 108137 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |